IndraLab
Statements
Methyltransferases methylates CDKN2A. 1 / 1
|
1
sparser
"Building on these premises, we systematically investigated the relationship between P16 methylation and the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib using both public datasets and cell models of P16 methylation induced by an artificial P16 -specific methyltransferase (P16-Dnmt) [ xref ]."